Skip to main content

Table 3 Delta change in serum levels of lipids [μg mL−1 serum] after 4 week treatments. Only lipids that change significantly differently between treatments are shown. The Spearman’s correlation between median serum change in lipid per treatment group and content of lipids in the corresponding food products is represented by a letter code: +: weak positive (rho < 0.6); ++ moderate positive (rho 0.7–0.9); +++: strong positive (rho > 0.9). All correlations are positive

From: Molecular effects of the consumption of margarine and butter varying in trans fat composition: a parallel human intervention study

Fatty Acids

Median wTFA

IQR wTFA (Q1, Q3)

Median iTFA

IQR iTFA (Q1, Q3)

Median rTFA

IQR rTFA (Q1, Q3)

PFDR-adjusted#

sp

[μg mL−1]

(n = 14)

 

(n = 14)

 

(n = 14)

   

SFA

 C12:0

10b

−15, 45

0b

−10, 15

-60a

−70, − 17.5

**

+

 C15:0

0a

−10, 10

-5a

−17.5, 7.5

30b

20, 40

***

++

 C17:0

5a

−10, 17.5

-5a

−17.5, 10

35b

30, 82.5

**

++

 C18:0

30a

− 368, 583

-125a

−320, 300

660b

190, 1783

*

+

 12Me-C15:0

0a

10, 0

0a

−10, 0

10b

10, 20

**

++

 14Me-C16:0

0a

−7.5, 10

0a

0, 10

10b

10, 20

**

++

 15Me-C17:0

0a

−7.5, 10

5a

−10, 10

30b

2.5, 50

*

++

PUFA cis

 C20:4c

0a

0, 10

-5a

−10, 0

20b

10, 35

**

++

 C20:5c

15a

0, 42.5

-10a

−5, 37.5

65b

30, 153

**

++

 C22:5c

10a

−10, 27.5

-10a

−20, 15

60b

32.5, 128

***

++

TFA

 C16:1 t9

0a

0, 10

0a

−10, 10

25b

10, 47.5

**

++

 C18:1 t6 + t7 + t8 + t9

10a

−17.5, 10

115b

92.5, 185

10a

−7.5, 20

**

+++

 C18:1 t10 + t11

0a

−10, 10

75b

27.5, 90

115c

95, 153

***

+++

 C18:1 t12

0a

0, 0

25b

12.5, 30

10b

0, 17.5

**

++

 C18:1 t13 + c6 + c7

0a

0, 10

30b

12.5, 38

20b

12.5, 30

**

+

 C18:2u

0a

−10, 7.5

0a

−10, 0

10b

10, 17.5

**

++

 C18:2 t9 + c12

0b

0, 7.5

-5a

−10, 0

10b

0, 10

**

+++

 C18:2c9 + t11

0a

−10, 7.5

0a

−17.5, 7.5

80b

52.5, 105

**

++

Sum parameters

 Total C18:1 t

10a

−7.5, 27.5

285b

163, 335

155b

103, 198

***

+

 Total C18:2 t (with CLA)

-5a

−17.5, 0

0a

−27.5, 10

80b

40, 123

***

++

 Total CLA

−10a

-10, 10

0a

−17.5, 10

75b

45, 115

***

++

 Total TFA (without CLA)

20a

−7.5, 47.5

275b

115, 328

165b

125, 225

***

+

 Total TFA (with CLA)

20a

−10, 62.5

290b

77.5, 338

225b

172.5, 337.5

***

+

 Total ω-3 FA

90ab

−40, 228

-15a

−200, 135

260b

102.5, 908

*

++

  1. Legend: #Kruskal wallis test results (PFDR-adjusted < 0.05: *, PFDR-adjusted < 0.01: **, PFDR-adjusted < 0.001: ***). Different letters (a, b, c) denote significant differences between treatment based on paired Wilcoxon signed-rank test (PFDR-adjusted < 0.05)
  2. Abbreviation: sp Spearman correlation, IQR Interquartile range. The FAs isomers that cannot be separated by the chromatographic steps are indicated by the plus sign “+” joining various cis (c) and/or trans (t) forms of the FAs